Sonovascular
Chapel Hill, US · Founded 2018 · North Carolina corporation · 3 known investors
Find your way into Sonovascular
107 people in our graph share verified history with the Sonovascular team — schools, employers, funds. One of them is your warm intro.
Alexa Lyonsunlockedknows Daniel Estay · together at Whitman School of Management at Syracuse University
×3knows the team · via Johnson & Johnson MedTech
×3knows the team · via Whitman School of Management at Syracuse University
×4knows the team · via University of Miami Business School
knows the team · via Duke's Office for Translation & Commercialization
Sonovascular is developing an interventional treatment for venous thromboembolism (VTE) that uses microbubble-mediated cavitation, delivered as a cath lab-based procedure without requiring ICU treatment. The company operates in the cardiovascular medical device space.
Founders & leadership
Sonovascular was founded in 2018 by Daniel Estay.
DE
Daniel EstayinFounderDaniel Estay is an Executive Officer and Director at Sonovascular, a cardiovascular medical device company developing interventional treatments for venous thromboembolism. He has built experience leading multidisciplinary teams in engineering, clinical, and regulatory functions for interventional device development.
WN
William N. StarlingNamed on SEC filing
Investors · 3
Reported raises · per SEC filings
Form D private placements$2.2M disclosed across 1 round · 2021
▶$2.2MraisedJan 2023 · 26 investors · Other Health CareRule 506(b)
▶$2.2MraisedJan 2023 · 26 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- William N. StarlingDirector
- Daniel EstayExecutive Officer, Director
- Offering amount
- $2.2M
- Amount sold
- $2.2M
- First sale
- Dec 2021
- Incorporated
- Corporation, North Carolina, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 6
by search overlapInnova Vascular15 shared keywordsInnova Vascular is a medical device company focused on the vascular space, led by a founder with a background in developing and commercializing vascular medical devices. The page provides limited detail about the company's specific products.
Bioworld13 shared keywordsBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.
NeuroVasc13 shared keywordsNeuroVasc Technologies develops catheter-based medical devices designed to treat stroke and other neurological conditions. The company serves patients and healthcare providers requiring neurovascular interventions.
Sonex Health11 shared keywordsSonex Health develops ultrasound-guided medical devices for orthopedic conditions, including UltraGuideCTR, a device that enables carpal tunnel release to be performed in a clinic setting. The company targets physicians and healthcare providers seeking minimally invasive treatments with faster patient recovery.
Boston Scientific11 shared keywordsBoston Scientific supports external researcher-initiated studies through its Investigator Sponsored Research program, which funds independent investigations addressing disease understanding and treatment gaps of interest to the medical community.
Sonavex10 shared keywordsSonavex develops medical device technologies focused on vascular access and related clinical applications, drawing on ultrasound-based imaging and monitoring products. The company serves clinical and surgical care settings, particularly in the dialysis and renal care space.
Companies competing with Sonovascular for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Sonovascular do?
- Sonovascular is developing an interventional treatment for venous thromboembolism (VTE) that uses microbubble-mediated cavitation, delivered as a cath lab-based procedure without requiring ICU treatment. The company operates in the cardiovascular medical device space.
- Who founded Sonovascular?
- Sonovascular was founded by Daniel Estay in 2018.
- Who are Sonovascular's investors?
- Sonovascular's investors include Band of Angels, ShangBay Capital LLC, Wolfpack Investor Network.
- How much funding has Sonovascular raised?
- Sonovascular has disclosed $2.2M raised across 1 round.
- Where is Sonovascular headquartered?
- Sonovascular is headquartered in Chapel Hill, US.